Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H43NO7 |
| Molecular Weight | 481.6221 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)OCC(=O)N(C)CC(=O)OCC
InChI
InChIKey=FYJLDICZGDFWKP-UHFFFAOYSA-N
InChI=1S/C26H43NO7/c1-4-6-7-8-9-10-11-12-13-14-15-16-19-32-25-18-17-22(34-25)26(30)33-21-23(28)27(3)20-24(29)31-5-2/h17-18H,4-16,19-21H2,1-3H3
| Molecular Formula | C26H43NO7 |
| Molecular Weight | 481.6221 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| From pathogenesis of acne vulgaris to anti-acne agents. | 2019-07 |
|
| Oily Skin: A review of Treatment Options. | 2017-08 |
|
| Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris. | 2017-07 |
|
| Anti-acne drugs in phase 1 and 2 clinical trials. | 2017-07 |
|
| Inhibition of Sebum Production with the Acetyl Coenzyme A Carboxylase Inhibitor Olumacostat Glasaretil. | 2017-07 |
|
| Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study. | 2017-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:14:00 GMT 2025
by
admin
on
Mon Mar 31 18:14:00 GMT 2025
|
| Record UNII |
4W6JDK2PLY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DE-161
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
DB12642
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
1261491-89-7
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
DTXSID301128270
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
C166791
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
89497391
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
10221
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
4W6JDK2PLY
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY | |||
|
100000174524
Created by
admin on Mon Mar 31 18:14:00 GMT 2025 , Edited by admin on Mon Mar 31 18:14:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |